Under construction – not a live service
Sign in

Hypertrophic cardiomyopathy trials, also abroad

88 open Hypertrophic cardiomyopathy trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.

CountryOpen trials
United States21
China19
United Kingdom14
Germany11
France8
All other countries

The same trial often runs in several countries

Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM has 13 sites in Spain and runs in 19 countries. If a site near you is full, another one may still take people.

See Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM in all 19 countries
Under construction, not live – Hypertrophic cardiomyopathy trials in Spain – Frontlight Research